Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Clinton Medicare Rx Plan Would Give Program Pricing "Clout" - Families USA

Executive Summary

Expanding Medicare to include prescription drug coverage would give the program a level of price bargaining power similar to that held by Canadian provinces, Families USA Executive Director Ron Pollack suggested during a July 31 press briefing to unveil a new drug cost study.

You may also be interested in...



PhRMA/BIO Get "Innovation" And "Modern Medicare" Into GOP Rhetoric

Sen. Frist (R-Tenn.) spotlighted "innovation" as the updated GOP theme for protecting the drug industry against anticipated attacks from the Gore campaign during an Aug. 3 speech to the Republican National Convention in Philadelphia.

Rx Re-Importation Bill Impact Could Be Limited By Canadian Export Laws

Canadian export regulations would limit the impact of pharmaceutical re-importation proposals pending in Congress, a former Canadian official said at a July 24 American Enterprise Institute conference in Washington, D.C.

Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data

Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011

UsernamePublicRestriction

Register

PS036464

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel